Dr. Cheryl Nickerson-Nutter is a seasoned R&D leader and the Executive Director of Three Lakes 12-20, where she focuses on accelerating therapies for pulmonary fibrosis. With a PhD from Johns Hopkins and a PMP certification, she has extensive experience in the pharmaceutical, biotech, and CRO industries, previously holding senior roles at Pfizer and Biogen.
She is passionate about empowering the global scientific community. This is demonstrated by her past role as Board Chair for Seeding Labs, a non-profit dedicated to helping scientists in developing countries conduct life-changing research by providing them with essential resources, training, and professional connections.
Her post-doctoral work at The Mayo Clinic involved studying the role of specific genes in transgenic mice to understand the development of reactive arthropathies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.